Trials / Sponsors / Gruppo Italiano Studio Linfomi

Gruppo Italiano Studio Linfomi

Academic / Other · 13 registered clinical trials.

Status	Trial	Phase	Started
Completed	Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders Chronic Lymphocytic Leukaemia	—	2010-11-01
Unknown	Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed My Multiple Myeloma	Phase 1 / Phase 2	2010-02-01
Unknown	Gonadal Toxicity in Women With Hodgkin Lymphoma Hodgkin Lymphoma	—	2009-07-01
Completed	The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification	—	2009-05-01
Unknown	Lenalidomide Plus Rituximab (R) in Non Follicular NHL Indolent Non Hodgkin Lymphoma	Phase 2	2009-04-01
Unknown	Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Chronic Lymphocytic Leukemia Stage A(0), Chronic Lymphocytic Leukemia Stage A(I), Chronic Lymphocytic Leukemia Stage A(II)	—	2007-02-01
Completed	VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma Non Hodgkin's Follicular Lymphoma	Phase 2	2006-08-01
Completed	Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients Wit Chemotherapy-Induced Nausea and Vomiting, Non Hodgkin's Lymphoma	Phase 2	2006-07-01
Completed	Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders Relapsed or Refractory Chronic Lymphoproliferative Disorders	—	2005-09-01
Completed	HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Inducti High-Grade Lymphomas	Phase 3	2000-10-01
Completed	Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) Advanced Hodgkin Disease	Phase 3	2000-04-01
Completed	Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab Follicular Lymphoma	Phase 2	2000-03-01
Completed	A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) fo Multiple Myeloma	Phase 2	—